Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Dendritic cell dysfunction and diabetic sensory neuropathy in the cornea
Nan Gao, Chenxi Yan, Patrick Lee, Haijing Sun, Fu-Shin Yu
Nan Gao, Chenxi Yan, Patrick Lee, Haijing Sun, Fu-Shin Yu
View: Text | PDF
Research Article Inflammation

Dendritic cell dysfunction and diabetic sensory neuropathy in the cornea

  • Text
  • PDF
Abstract

Diabetic peripheral neuropathy (DPN) often leads to neurotrophic ulcerations in the cornea and skin; however, the underlying cellular mechanisms of this complication are poorly understood. Here, we used post-wound corneal sensory degeneration and regeneration as a model and tested the hypothesis that diabetes adversely affects DC populations and infiltration, resulting in disrupted DC-nerve communication and DPN. In streptozotocin-induced type 1 diabetic mice, there was a substantial reduction in sensory nerve density and the number of intraepithelial DCs in unwounded (UW) corneas. In wounded corneas, diabetes markedly delayed sensory nerve regeneration and reduced the number of infiltrating DCs, which were a major source of ciliary neurotrophic factor (CNTF) in the cornea. While CNTF neutralization retarded reinnervation in normal corneas, exogenous CNTF accelerated nerve regeneration in the wounded corneas of diabetic mice and healthy animals, in which DCs had been locally depleted. Moreover, blockade of the CNTF-specific receptor CNTFRα induced sensory nerve degeneration and retarded regeneration in normal corneas. Soluble CNTFRα also partially restored the branching of diabetes-suppressed sensory nerve endings and regeneration in the diabetic corneas. Collectively, our data show that DCs mediate sensory nerve innervation and regeneration through CNTF and that diabetes reduces DC populations in UW and wounded corneas, resulting in decreased CNTF and impaired sensory nerve innervation and regeneration.

Authors

Nan Gao, Chenxi Yan, Patrick Lee, Haijing Sun, Fu-Shin Yu

×

Figure 6

Effects of CNTF-neutralizing Ab on sensory nerve reinnervation in NL and DM mouse corneas.

Options: View larger image (or click on image) Download as PowerPoint
Effects of CNTF-neutralizing Ab on sensory nerve reinnervation in NL and...
(A) NL and DM corneas were subconjunctivally injected with CNTF-neutralizing Ab or IgG as the control 4 hours before epithelial debridement. A 2-mm wound was made at the center of the cornea and allowed to heal for 22 hours. The remaining fluorescence-stained wounds were photographed. Note the similar sizes of the wounds with or without CNTF-neutralizing Ab treatment. (B) Regeneration of sensory nerve endings was assessed by WMCM at 1 dpw with β-tubulin III staining, and the micrographs were taken near the limbal region. Note the lack of sensory nerve endings in the CNTF-neutralizing Ab–treated corneas. Scale bar: 91.4 μm. (C) Wound-healing rates presented as the percentage of healed cornea 22 hours after epithelial debridement (n = 5). **P < 0.01, by 2-way ANOVA with Bonferroni’s post test. (D) Corneal innervation was quantified as the percentage of threshold area positive for β-tubulin III staining in the representative confocal images shown in B. Results are representative of 2 independent experiments (n = 5 each). **P < 0.01, by 2-way ANOVA with Bonferroni’s post test.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts